feed,title,long_url,short_url
Benzinga,Cancer Player Kronos Bio To Stop Lanraplenib Combo Therapy Blood Cancer Study,https://benzinga.com/analyst-ratings/analyst-color/23/12/36310217/cancer-player-kronos-bio-to-stop-lanraplenib-combo-therapy-blood-cancer-study,https://da.gd/moWB8O
